Latest Nociception Stories

024 Pain Management System Relieves Physical, Mental Effects of Arthritis

2012-07-17 02:26:39

NEW YORK, July 17, 2012 /PRNewswire/ -- New studies reveal a strong link between arthritis patients and reports of anxiety and depression. The makers of 024 Pain Management System explain this connection and encourage all sufferers to seek improved care. As with many illnesses, the combination of chronic pain and the lack of relief through proper treatment can lead to severe mental illness. A recent article from DailyRx introduces a new study that connects a strong likelihood that...

ESTEVE Announces Publication of Key Preclinical Data for a Novel Oral, First-in-class New Chemical Entity (NCE) Sigma-1 Receptor Antagonist (E-52862), that has Completed Phase I and Initiated its Phase II Clinical Trial Program

2012-07-16 22:20:36

BARCELONA, July 17, 2012 /PRNewswire/ -- - The sigma-1 receptor (S1R) is an important development target for innovative medications to treat neuropathic pain, for which new medications are much needed. - Developed by ESTEVE, E-52862 is a potent, highly selective NCE with a novel mechanism of action (S1R antagonism) currently being evaluated for the treatment of pain. - In studies conducted to date in...

The Center for Regenerative Medicine Introduces Genorthix System

2012-07-16 23:00:22

"The Center for regenerative medicine introduces Genorthix system," according to Roman Garcia PT. Miami, FL (PRWEB) July 16, 2012 "The Center for regenerative medicine introduces Genorthix system," according to Roman Garcia PT. "The Genorthix system combines the fractal geometric reconstitutive effect of ultra-sound energy with the re-hydrating and pain reliever properties contained in the Genorthix Penetrating Pain Reliever cream. Now available to the public for...

ESTEVE Communicates its R&D Through a New Interactive Platform

2012-07-11 22:21:14

BARCELONA, July 12, 2012 /PRNewswire/ -- This site is part of the http://www.esteve.com [http://www.esteve.com/investigacion-desarrollo ] corporate web portal - ESTEVE's new website provides consise and updated information on its projects under development. Among these is the S1RA (Sigma-1 Receptor Antagonist), a new chemical entity, presently in Clinical Phase II, for treating several types of pain - In addition to...

Manhattan Sports Therapy: Your Path to Conservative Pain Relief

2012-07-11 10:23:39

NEW YORK, July 11, 2012 /PRNewswire/ -- Dedicated to the latest non-surgical, non-invasive physical treatments, New York City (NYC) spine expert Dr. Rolland Nemirovsky, is launching a new site to help patients of all activity levels understand the causes and treatment options for their musculoskeletal pain symptoms. Centrally located in Midtown Manhattan, Dr. Nemirovsky diagnoses chronic pain and acute pain by combining the accelerated principals of sports medicine, physical...

Spine Pain Management Opens Two Additional Affiliate Diagnostic Centers in Florida

2012-07-11 02:25:32

HOUSTON, July 11, 2012 /PRNewswire/ -- Spine Pain Management, Inc. (OTC QB:SPIN), a medical services and technology company, today announced that it has opened affiliate diagnostic centers in Brandon, Florida and Lakeland, Florida, thereby increasing its geographic reach across Central Florida. In addition to its two flagship locations in Texas, Spine Pain Management now has six Florida-based diagnostic centers (Tampa, Orlando, Jacksonville, Sarasota, Brandon and Lakeland), providing...

American Academy of Pain Medicine Applauds FDA Action to Enhance Patient Safety on Prescribing Opioids; Offers AAPM Safe Opioid Prescribing Course as Educational Model

2012-07-09 10:23:53

GLENVIEW, Ill., July 9, 2012 /PRNewswire-USNewswire/ -- The American Academy of Pain Medicine, which represents 2,600 pain physicians and treatment teams, issued the following statement today in response to the FDA's issuance of the Risk Evaluation and Mitigation Strategy (REMS) for opioids: As the premiere medical association of pain physicians, we applaud the FDA's issuance of the Risk Evaluation and Mitigation Strategy (REMS) for opioids. It is a huge leap forward. We are pleased...

Pain Intensity Increases With TV Terrorist Attacks

2012-07-02 21:47:03

It's official, news media are a pain "Exposure to media coverage of terrorist missile attacks increases pain levels in people already suffering from chronic pain," according to a new study by Ben-Gurion University of the Negev (BGU) researchers. "Does War Hurt? Effects of Media Exposure After Missile Attacks on Chronic Pain," published in the online version of the Journal of Clinical Psychology in Medical Settings, showed that exposure to the attacks through the media predicted an...

Chronic Pain - It's All In Your Head

2012-07-02 04:47:54

redOrbit Staff & Wire Reports - Your Universe Online Researchers at Northwestern University claim that they have discovered why one person who suffers an injury can recover completely, while another individual suffering a similar injury will go on to suffer chronic pain. What they have discovered is that the difference is all in a person's head. To clarify, the scientists used longitudinal brain imaging to track subjects with recent back injuries, and discovered that two sections of...

Spine Pain Management, Inc. Completes $500,000 Private Placement

2012-06-29 02:24:02

HOUSTON, June 29, 2012 /PRNewswire/ -- Spine Pain Management, Inc. (OTC QB:SPIN), a medical services and technology company, today announced that it closed on the non-brokered private placement of a 12% Convertible Promissory Note generating proceeds of $500,000. The promissory note provides for quarterly payments of interest only with a final balloon payment of principal and interest due on March 27, 2014. Up to half the principal amount of the promissory note may be...